Clinical trial
Study to Examine the Effect of Betahistine on Body Weight Gain Due to Olanzapine…
NCT00428168 · OBEcure Ltd., Industry · Terminated
Key facts
| NCT number | NCT00428168 |
|---|---|
| Title | Study to Examine the Effect of Betahistine on Body Weight Gain Due to Olanzapine Treatment |
| Official title | A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Examine the Effect of Betahistine on Body Weight Gain Due to Olanzapine Treatment |
| Lead sponsor | OBEcure Ltd., Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Weight Gain |
| Intervention type | Drug |
| Interventions | Betahistine |
| Enrollment | 36 |
| Start date | Mar 1, 2007 |
| Primary completion | Aug 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Jan 29, 2007 |
| Last update posted | Oct 15, 2015 |
| Countries | Canada, Israel |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: